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S3-7 Figure S1 . Sequence alignment of IRE1 cytosolic domain in different organism; yeast structure (PDB code: 3LJ1),murine (PDB code: 4PL3), and human (PDB code: 4U6R) using Bioluminate 2 in Schrödingher 3 . Identical residues are matched by same colour. Identical residues in the kinase active site, within a distance of 5.0 Å from the co-crystallized ligands, are highlighted using blue boxes. S8 
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